Mitsubishi Tanabe Pharma America
Kellen Voss is an experienced professional in the field of medical affairs, with a background in molecular biology. They have held various roles in companies such as Mitsubishi Tanabe Pharma America, UCB, and Thermo Fisher Scientific. Kellen's expertise lies in transitioning developmental products to market, building relationships with internal and external stakeholders, and conducting competitive intelligence. Their educational background includes a Ph.D. in Molecular Biology from The University of Kansas.
This person is not in any offices
Mitsubishi Tanabe Pharma America
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf